Jordan Elm to Monoamine Oxidase Inhibitors
This is a "connection" page, showing publications Jordan Elm has written about Monoamine Oxidase Inhibitors.
Connection Strength
0.277
-
Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson's Disease: An?Analysis?of?NET-PD LS1. J Parkinsons Dis. 2017; 7(1):117-127.
Score: 0.142
-
Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo-controlled trial. Mov Disord. 2016 05; 31(5):709-14.
Score: 0.135